Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Axitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 20 Kidney Neoplasms 6 Neoplasms 5 Uterine Cervical Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Melanoma 2 Endometrial Neoplasms 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 cT2a N0NxM0 Renal Tumor 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Radiation Therapy 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Kidney Diseases 1 Gastrointestinal Stromal Tumors 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Cystadenocarcinoma, Serous 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡